Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HOMAN ABDOLLAHZADEH

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1184634826
CMS profile
1222510
Location
PALM SPRINGS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$488.26

35 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $488.26 35

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $383.57 30
Janssen Biotech, Inc. $46.18 2
Alnylam Pharmaceuticals Inc. $26.89 1
Merck Sharp & Dohme LLC $16.13 1
PFIZER INC. $15.49 1

Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HOMAN ABDOLLAHZADEH

NPI 1184634826 · CMS profile ID 1222510

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

PALM SPRINGS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1184634826?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HOMAN ABDOLLAHZADEH, NPI 1184634826, CMS profile ID 1222510. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1184634826?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). HOMAN ABDOLLAHZADEH, NPI 1184634826, CMS profile ID 1222510. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1184634826?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
HOMAN ABDOLLAHZADEH, NPI 1184634826, CMS profile ID 1222510, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1184634826?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

35 matching records · $488.26 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 35 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–35 of 35.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $23.3712/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164352 CMS
ABBVIE INC. $4.1412/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164350 CMS
ABBVIE INC. $5.6211/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164348 CMS
ABBVIE INC. $4.0711/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164346 CMS
ABBVIE INC. $27.6210/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164342 CMS
ABBVIE INC. $8.9410/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164344 CMS
Janssen Biotech, Inc. $20.1110/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078316524 CMS
ABBVIE INC. $13.2210/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164340 CMS
ABBVIE INC. $4.5609/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164338 CMS
ABBVIE INC. $7.7009/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164336 CMS
ABBVIE INC. $2.0809/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164332 CMS
ABBVIE INC. $15.7209/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164334 CMS
ABBVIE INC. $10.8909/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164330 CMS
ABBVIE INC. $12.8909/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164328 CMS
ABBVIE INC. $6.2508/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164326 CMS
Merck Sharp & Dohme LLC $16.1308/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141866789 CMS
ABBVIE INC. $3.8108/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164324 CMS
PFIZER INC. $15.4908/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131845013 CMS
ABBVIE INC. $11.0008/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164322 CMS
ABBVIE INC. $3.8708/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164320 CMS
ABBVIE INC. $8.2507/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164318 CMS
ABBVIE INC. $123.8607/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164316 CMS
ABBVIE INC. $3.2707/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164314 CMS
ABBVIE INC. $13.1906/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164312 CMS
ABBVIE INC. $3.9406/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164310 CMS
Janssen Biotech, Inc. $26.0706/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078316574 CMS
ABBVIE INC. $4.5305/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164308 CMS
ABBVIE INC. $4.1005/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164306 CMS
ABBVIE INC. $4.4704/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164304 CMS
ABBVIE INC. $4.0904/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164302 CMS
ABBVIE INC. $3.8403/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164300 CMS
Alnylam Pharmaceuticals Inc. $26.8903/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125826359 CMS
ABBVIE INC. $20.7202/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164298 CMS
ABBVIE INC. $2.8501/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164296 CMS
ABBVIE INC. $20.7101/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103164294 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $153.95 9
PY2020 $111.03 6
PY2021 $1,953.43 20
PY2022 $332.44 20
PY2023 $278.62 27
PY2024 $488.26 35
PY2025 $469.44 41

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $12,175.00 7
PY2024 Principal investigator $30,640.00 3
PY2023 Principal investigator $10,000.00 2
PY2022 Principal investigator $10,996.00 14
PY2021 Principal investigator $36,275.00 24
PY2020 Principal investigator $118,300.83 38
PY2019 Recipient $2,656.25 4
PY2019 Principal investigator $244,314.00 52

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

56 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Intercept Pharmaceuticals, Inc. $18,697.50 11/27/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702080279
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,097.75 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079601
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,134.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079607
Principal investigator 1 Intercept Pharmaceuticals, Inc. $450.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079611
Principal investigator 1 Intercept Pharmaceuticals, Inc. $150.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079613
Principal investigator 1 Intercept Pharmaceuticals, Inc. $5,345.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079621
Principal investigator 1 Intercept Pharmaceuticals, Inc. $75.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079627
Principal investigator 1 Intercept Pharmaceuticals, Inc. $750.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079629
Principal investigator 1 Intercept Pharmaceuticals, Inc. $225.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079635
Principal investigator 1 Intercept Pharmaceuticals, Inc. $300.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079641
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,842.75 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079645
Principal investigator 1 Intercept Pharmaceuticals, Inc. $100.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079651
Principal investigator 1 Intercept Pharmaceuticals, Inc. $145.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079657
Principal investigator 1 Intercept Pharmaceuticals, Inc. $5,195.00 11/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079661
Principal investigator 1 Intercept Pharmaceuticals, Inc. $50.00 11/14/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079599
Principal investigator 1 Intercept Pharmaceuticals, Inc. $805.00 11/07/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079433
Principal investigator 1 Intercept Pharmaceuticals, Inc. $270.00 11/07/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079437
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,028.50 11/07/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079443
Principal investigator 1 Intercept Pharmaceuticals, Inc. $50.00 10/23/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079101
Principal investigator 1 Intercept Pharmaceuticals, Inc. $30,570.75 10/23/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702079111
Principal investigator 1 Intercept Pharmaceuticals, Inc. $13,357.00 10/09/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077803
Principal investigator 1 Intercept Pharmaceuticals, Inc. $3,500.00 10/09/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077807
Principal investigator 1 Intercept Pharmaceuticals, Inc. $100.00 10/09/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077812
Principal investigator 1 Intercept Pharmaceuticals, Inc. $75.00 10/09/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077815
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,600.00 10/09/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077821
Principal investigator 1 Intercept Pharmaceuticals, Inc. $8,325.00 10/09/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077825
Principal investigator 1 Intercept Pharmaceuticals, Inc. $18,711.00 09/25/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077415
Principal investigator 1 Intercept Pharmaceuticals, Inc. $450.00 09/25/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077421
Principal investigator 1 Intercept Pharmaceuticals, Inc. $5,959.25 09/25/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077427
Principal investigator 1 Intercept Pharmaceuticals, Inc. $650.00 09/25/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702077432
Principal investigator 1 Allergan Inc. $2,500.00 09/17/2019 Non-covered Recipient Entity
PALMTREE CLINICAL RESEARCH INCORPORATED
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 670075721
Principal investigator 1 Allergan Inc. $8,500.00 09/17/2019 Non-covered Recipient Entity
PALMTREE CLINICAL RESEARCH INCORPORATED
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 670075731
Principal investigator 1 Allergan Inc. $400.00 09/17/2019 Non-covered Recipient Entity
PALMTREE CLINICAL RESEARCH INCORPORATED
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 670075811
Principal investigator 1 Allergan Inc. $1,200.00 09/17/2019 Non-covered Recipient Entity
PALMTREE CLINICAL RESEARCH INCORPORATED
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 670075840
Principal investigator 1 Allergan Inc. $3,500.00 09/17/2019 Non-covered Recipient Entity
PALMTREE CLINICAL RESEARCH INCORPORATED
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 670075883
Principal investigator 1 Intercept Pharmaceuticals, Inc. $14,411.25 09/13/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702076829
Principal investigator 1 Intercept Pharmaceuticals, Inc. $12,152.50 08/07/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702075273
Principal investigator 1 Intercept Pharmaceuticals, Inc. $17,921.25 07/26/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702075245
Principal investigator 1 Intercept Pharmaceuticals, Inc. $19,500.75 06/19/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702073539
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,538.00 05/28/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702072145
Principal investigator 1 Intercept Pharmaceuticals, Inc. $4,995.00 05/13/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702070705
Principal investigator 1 Intercept Pharmaceuticals, Inc. $9,348.75 04/26/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702070266
Principal investigator 1 Intercept Pharmaceuticals, Inc. $7,500.00 04/25/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702070143
Principal investigator 1 Intercept Pharmaceuticals, Inc. $50.00 04/25/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702070147
Recipient Dova Pharmaceuticals $250.00 04/09/2019 Covered Recipient Physician Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420677
Recipient Dova Pharmaceuticals $500.00 04/09/2019 Covered Recipient Physician Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420679
Recipient Dova Pharmaceuticals $1,000.00 04/09/2019 Covered Recipient Physician Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420681
Recipient Dova Pharmaceuticals $906.25 04/09/2019 Covered Recipient Physician Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420683
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,538.00 04/05/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702069267
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,500.00 04/03/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702068565
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,000.00 04/03/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702068575
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,500.00 04/03/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702068579
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,500.00 04/03/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702068586
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,500.00 04/03/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702068589
Principal investigator 1 Intercept Pharmaceuticals, Inc. $7,000.00 04/03/2019 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
1009742 No dispute reported 06/30/2026 702068597
Principal investigator 1 Dova Pharmaceuticals $250.00 03/05/2019 Non-covered Recipient Entity
The Copernicus Group Inc dba Copernicus Group IRB
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420597